Renal Denervation Planning With Volume-of-Influence Modeling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing denervation therapies lack precision in targeting overactive nerves while minimizing impact on non-target tissues, leading to inefficiencies and potential adverse effects.

Innovation Solution

A computer model-based system determines patient-specific tissue characteristics and anatomy to estimate the volume of influence of denervation therapy, allowing for precise delivery of electrical, chemical, or thermal energy to target nerves while avoiding non-target tissues.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If denervation therapy is delivered to target nerves, then nerve activity is reduced or eliminated, but non-target tissues may be adversely affected

Engineering Contradiction:
Improvenerve denervation efficacyVSAvoiddamage to non-target tissues
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The system performs preliminary actions by generating a computer model of the patient's anatomy and estimating the volume of influence before delivering denervation therapy. This allows the operator to visualize and plan the therapy delivery, ensuring that the denervation stimulus will affect the target nerve while avoiding non-target tissues. The preliminary modeling and visualization enable precise parameter selection to achieve effective denervation without adverse effects.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system incorporates feedback by using the computer model and volume of influence estimation to guide and adjust denervation therapy delivery. The visual representation of the volume of influence provides real-time feedback to the operator about the expected effect of therapy parameters, allowing for optimization of delivery settings to achieve effective nerve denervation while minimizing impact on surrounding non-target tissues.

Inventive Principle:
Principle #23Feedback

2Measurement precision

If denervation therapy parameters are increased to improve nerve targeting, then denervation efficacy increases, but impact on non-target tissues increases

Engineering Contradiction:
Improvenerve targeting precisionVSAvoidaffected tissue volume
Core Design Contradiction:
Measurement precisionVSArea of stationary object

Solution Approach 1:

The system applies local quality by providing detailed visual information about the spatial distribution of the volume of influence at different locations and orientations. This allows the operator to select therapy parameters that concentrate the denervation effect precisely on the target nerve while limiting the affected area in surrounding tissues. The localized visual feedback enables optimization of each therapy delivery location independently.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The system transitions from one-dimensional parameter adjustment to three-dimensional visualization and planning by generating a computer model and estimating the volume of influence in 3D space. This dimensional expansion allows the operator to understand and control the spatial distribution of therapy effects, enabling precise targeting of the nerve while avoiding excessive spread to non-target tissues through strategic selection of delivery location and orientation.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Measurement precision

If computer modeling and visualization are added to denervation therapy, then targeting precision improves, but system complexity increases

Engineering Contradiction:
Improvevolume of influence estimation accuracyVSAvoidsystem architecture complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The system creates a digital copy or model of the patient's anatomy and the expected volume of influence, allowing visualization and planning without adding physical complexity to the actual therapy delivery device. This virtual modeling approach enables precise targeting capabilities while keeping the physical system relatively simple, as the computational model handles the complexity of predicting and visualizing therapy effects.

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enhances the efficacy and efficiency of denervation therapy by accurately targeting nerves and minimizing impact on non-target tissues, reducing procedure time and adverse effects.

Implementation Method 1

delivering electrical, chemical, light or laser, microwave, radiation, and/or thermal energy to a nerve in order to render the nerve inert, inactive, or otherwise completely or partially reduced in function

Methodology Applied
Scientific EffectThermal energy delivery: Heating

Implementation Method 2

delivering electrical, chemical, light or laser, microwave, radiation, and/or thermal energy to a nerve

Methodology Applied
Scientific EffectElectrical energy delivery: Electrical Resistance

Implementation Method 3

delivering electrical, chemical, light or laser, microwave, radiation, and/or thermal energy to a nerve

Methodology Applied
Scientific EffectLight or laser energy delivery: Laser

Implementation Method 4

delivering electrical, chemical, light or laser, microwave, radiation, and/or thermal energy to a nerve

Methodology Applied
Scientific EffectMicrowave energy delivery: Microwave Radiation

Implementation Method 5

The volume of influence may be estimated based on a computer model generated from a digital reconstruction of a region of a patient, the digital reconstruction indicating parameters such as tissue types and relative locations

Methodology Applied
Scientific EffectComputer modeling:

Data Source

PatentEP3742994B1Denervation therapy
Publication Date: 2026.03.11 MEDTRONIC IRELAND MFG UNLIMITED CO
  • EP3742994B1 patent drawingFigure 1A~1B
  • EP3742994B1 patent drawingFigure 2
  • EP3742994B1 patent drawingFigure 3

AI summary

Example systems and techniques for denervation, for example, renal denervation. In some examples, a processor determines one or more tissue characteristics of tissue proximate a target nerve and a blood vessel. The processor may generate, based on the one or more tissue characteristics, an estimated volume of influence of denervation therapy delivered by a therapy delivery device disposed within the blood vessel. The processor may generate a graphical user interface including a graphical representation of the tissue proximate the target nerve and the blood vessel and a graphical representation of the estimated volume of influence.